Chugai Pharmaceutical Co., Ltd. Share Price
Stocks
4519
JP3519400000
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Japan Exchange
07:30:00 02/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 6,032.00 JPY | -2.32% |
|
-8.83% | -26.82% |
| 09-23 | Chugai Pharma to Boost Capex by 50% to Expand In-House Production | MT |
| 08-21 | Alvotech Enters Licensing, Commercialization Deal for Two Biosimilars in US, Certain Asian Markets | MT |
| Market Cap | 9,924B 62.92B 55.91B 52.18B 47.56B 89.7B 6,049B 90.53B 631B 245B 3,092B 236B 231B | P/E 2026 * |
19.7x | P/E 2027 * | 17.1x |
|---|---|---|---|---|---|
| Enterprise Value | 9,013B 57.15B 50.77B 47.39B 43.19B 81.46B 5,494B 82.22B 573B 222B 2,808B 215B 210B | EV / Sales 2026 * |
6.52x | EV / Sales 2027 * | 5.75x |
| Free-Float |
38.12% | Yield 2026 * |
2.24% | Yield 2027 * | 2.56% |
| Markets | Quality | ||
|---|---|---|---|
Japan Exchange
| 4519 | Delayed | |
OTC Markets
| CHGCF | Delayed | |
|
Mexican S.E.
| 4519 N | End-of-day quote | |
|
Tradegate
| CUP | Real-time | |
|
Boerse Muenchen
| CUP | Real-time | |
|
Deutsche Boerse AG
| CUP | Delayed | |
|
Börse Stuttgart
| CUP | Delayed |
Last Transcript: Chugai Pharmaceutical Co., Ltd.
| 1 day | -2.32% | ||
| 1 week | -8.83% | ||
| Current month | -3.10% | ||
| 1 month | -11.71% | ||
| 3 months | -18.71% | ||
| 6 months | -34.42% | ||
| Current year | -26.82% |
| 1 week | 5,974 |  | 6,513 |
| 1 month | 5,974 | | 6,873 |
| Current year | 5,974 | | 10,700 |
| 1 year | 5,974 | | 10,700 |
| 3 years | 4,234 | | 10,700 |
| 5 years | 3,191 | | 10,700 |
| 10 years | 1,003.33 | | 10,700 |
| Manager | Title | Age | Since |
|---|---|---|---|
Osamu Okuda
CEO | Chief Executive Officer | 63 | 28/02/2021 |
Iwaaki Taniguchi
DFI | Director of Finance/CFO | 59 | 27/03/2024 |
Kazuhiko Nishi
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Osamu Okuda
BRD | Director/Board Member | 63 | 29/02/2020 |
Iwaaki Taniguchi
BRD | Director/Board Member | 59 | 27/03/2024 |
| Director/Board Member | 51 | 28/02/2025 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.32% | -8.83% | -11.64% | +33.04% | 62.92B | |
| -0.61% | -3.43% | +39.40% | +112.31% | 1,019B | |
| -1.02% | -5.60% | +37.67% | +65.02% | 617B | |
| +1.11% | -0.58% | +11.10% | +77.28% | 464B | |
| +0.34% | -3.01% | +61.21% | +40.71% | 356B | |
| -0.95% | -4.05% | +21.60% | +39.37% | 333B | |
| -1.46% | -2.89% | +11.84% | +24.60% | 267B | |
| -1.35% | -5.43% | -4.69% | +8.40% | 244B | |
| -1.04% | -2.79% | +35.52% | +51.34% | 218B | |
| -1.87% | -4.10% | +30.92% | +95.33% | 179B | |
| Average | -0.44% | -3.94% | +23.29% | +54.74% | 376.01B | |
| Weighted average by Cap. | +0.38% | -3.42% | +29.81% | +68.36% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1,383B 8.77B 7.79B 7.27B 6.63B 12.5B 843B 12.61B 87.97B 34.09B 431B 32.91B 32.2B | 1,526B 9.67B 8.59B 8.02B 7.31B 13.79B 930B 13.92B 97.07B 37.62B 475B 36.32B 35.53B |
| Net income | 504B 3.2B 2.84B 2.65B 2.42B 4.56B 307B 4.6B 32.09B 12.44B 157B 12.01B 11.75B | 581B 3.68B 3.27B 3.05B 2.78B 5.25B 354B 5.3B 36.96B 14.32B 181B 13.83B 13.53B |
| Net Debt | -911B -5.78B -5.13B -4.79B -4.37B -8.24B -555B -8.31B -57.98B -22.47B -284B -21.69B -21.22B | -1,150B -7.29B -6.48B -6.05B -5.51B -10.4B -701B -10.49B -73.19B -28.36B -358B -27.38B -26.79B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/10/26 | JP¥6,032.00 | -2.32% | 4,546,000 |
| 01/10/26 | JP¥6,175.00 | -0.80% | 4,383,000 |
| 30/09/26 | JP¥6,225.00 | +2.12% | 9,460,400 |
| 29/09/26 | JP¥6,096.00 | -4.18% | 4,741,300 |
| 28/09/26 | JP¥6,362.00 | -3.84% | 4,151,800 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4519 Stock
Select your edition
All financial news and data tailored to specific country editions
